Lista de obras - Hendrik B Feys - Dominio Público Uruguay

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

artículo científico publicado en 2017

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device

scientific article published on 21 March 2019

ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis

artículo científico publicado en 2007

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

artículo científico publicado en 2008

ADAMTS13 in health and disease

artículo científico publicado en 2009

ADAMTS13's tail tale

artículo científico publicado en 2009

Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction

artículo científico publicado en 2010

Aggregates in platelet concentrates

scientific article published on 19 September 2014

Allosteric activation of ADAMTS13 by von Willebrand factor.

artículo científico publicado en 2014

Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus

scientific article published on 01 April 2006

Biomolecular Consequences of Platelet Pathogen Inactivation Methods

scientific article published on 27 June 2018

Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates

scientific article published on 24 May 2018

Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure*

artículo científico publicado en 2007

Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers

artículo científico publicado en 2006

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.

artículo científico publicado en 2006

Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary

artículo científico publicado en 2020

Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma

scientific article published on 01 October 2007

High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis

artículo científico publicado en 2017

Impact of cold storage on platelets treated with Intercept pathogen inactivation

scientific article published on 12 June 2019

Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.

artículo científico publicado en 2010

Inherited traits affecting platelet function.

artículo científico publicado en 2008

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons

artículo científico publicado en 2012

Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.

artículo científico publicado en 2015

Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis

artículo científico publicado en 2011

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation

artículo científico publicado en 2018

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

artículo científico publicado en 2016

Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain

artículo científico publicado en 2004

Multi-step binding of ADAMTS-13 to von Willebrand factor.

artículo científico publicado en 2009

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

artículo científico publicado en 2009

Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage

artículo científico publicado en 2013

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

artículo científico publicado en 2015

Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.

artículo científico publicado en 2013

Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction.

artículo científico publicado en 2013

Persistent aggregates in apheresis platelet concentrates

artículo científico publicado en 2015

Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.

artículo científico publicado en 2016

Platelets at work in primary hemostasis.

artículo científico publicado en 2011

Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing

artículo científico publicado en 2016

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

artículo científico publicado en 2011

Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.

artículo científico publicado en 2014

Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.

artículo científico publicado en 2014

The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates

artículo científico publicado en 2015

The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.

artículo científico publicado en 2010

The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation

artículo científico publicado en 2019

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion

artículo científico publicado en 2019

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

artículo científico publicado en 2005

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

artículo científico publicado en 2010

Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro

artículo científico publicado en 2015

Lista de obras de Hendrik B Feys

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device

ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

ADAMTS13 in health and disease

ADAMTS13's tail tale

Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction

Aggregates in platelet concentrates

Allosteric activation of ADAMTS13 by von Willebrand factor.

Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus

Biomolecular Consequences of Platelet Pathogen Inactivation Methods

Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates

Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure*

Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.

Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary

Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma

High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis

Impact of cold storage on platelets treated with Intercept pathogen inactivation

Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.

Inherited traits affecting platelet function.

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons

Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.

Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain

Multi-step binding of ADAMTS-13 to von Willebrand factor.

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.

Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction.

Persistent aggregates in apheresis platelet concentrates

Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.

Platelets at work in primary hemostasis.

Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.

Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.

The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates

The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.

The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro